Sign in to view content

Characteristics and the Need for Supplementation Following 0.19mg Fluocinolone Acetonide (FAc) in Diabetic Macular Edema (DME) Patients

Victor Hugo Gonzalez, MD

Video
Published 2021

Related

Diabetic Retinopathy and the MyVisionTrack App Study (DRAMA)
Samuel K. Steven Houston, MD, FASRS
On Demand Cases, Courses, and Papers
2017
Interim 12-Month Results from PALADIN in Diabetic Macular Patients Receiving ILUVIEN: Analysis of the Prior Dexamethasone Cohort
Daniel F. Kiernan, MD, FACS
On Demand Cases, Courses, and Papers
2019
Impact of Race on Vision Outcomes in RanibizumabTreated Patients With Diabetic Macular Edema: A Meta-Analysis of 5 Clinical Trial
M. Ali Khan, MD, FACS, FASRS
Updates from the Field
2021

Category: Diabetic Retinopathy

See more